leukemia / bone marrow transplant (bmt) program of british ...€¦ · the new marrow and prevent...
TRANSCRIPT
TransplantModule
Patient Education Manual
Leukemia / Bone Marrow Transplant (BMT)Program of British Columbia
Leukemia/BMT Inpatient Unit (T15A) Reception/Unit Clerk 604-875-4343
Leukemia/BMT Daycare Outpatient Unit (CP6 A/B) Reception/UnitClerk604-875-4073•Afterhours,calltheInpatientUnit604-875-4343
Cell Separator Unit – CSU (CP6 C) Reception604-875-4962•BookingClerk604-875-4626 AfterHourscallLocatingandaskfortheCSUnurseordoctoroncall604-875-5000
BMT Doctor(writeyourdoctor’snumberinhere)__________________________________
BMT Coordinators BrankaDeutsch(unrelated) 604-875-4831 CarolynFrew 604-875-4111,local67486 JanetBury(unrelated) 604-875-4111,local67485 MaryChan 604-875-4939 SheilaWong 604-875-4111,local63432 ValerieCampbell 604-875-4111,local68549 Fax 604-875-5678or604-875-4910
Social Workers T15InpatientUnitOffice 604-875-4941 CP6DaycareOutpatientUnitOffice 604-875-4697
Pharmacist 604-875-4077
Occupational Therapist 604-875-4343
Nutritionist 604-875-4343
Physiotherapist 604-875-4343
Leukemia/BMT Program Administration Office 604-875-4863
Medical Services Plan of BC and Fair Pharmacare 604-683-7151or1-800-663-7100
Leukemia/BMT Inpatient Unit (T15A) Reception/Unit Clerk 604-875-4343
Leukemia/BMT Daycare Outpatient Unit (CP6 A/B) Reception/UnitClerk604-875-4073•Afterhours,calltheInpatientUnit604-875-4343
Cell Separator Unit – CSU (CP6 C) Reception604-875-4962•BookingClerk604-875-4626 AfterHourscallLocatingandaskfortheCSUnurseordoctoroncall604-875-5000
BMT Doctor(writeyourdoctor’snumberinhere)__________________________________
BMT Coordinators BrankaDeutsch(unrelated) 604-875-4831 CarolynFrew 604-875-4111,local67486 JanetBury(unrelated) 604-875-4111,local67485 MaryChan 604-875-4939 SheilaWong 604-875-4111,local63432 ValerieCampbell 604-875-4111,local68549 Fax 604-875-5678or604-875-4910
Social Workers T15InpatientUnitOffice 604-875-4941 CP6DaycareOutpatientUnitOffice 604-875-4697
Pharmacist 604-875-4077
Occupational Therapist 604-875-4343
Nutritionist 604-875-4343
Physiotherapist 604-875-4343
Leukemia/BMT Program Administration Office 604-875-4863
Medical Services Plan of BC and Fair Pharmacare 604-683-7151or1-800-663-7100
Contents
Introduction 1TransplantBasics 2TypesofBlood&MarrowTransplant ........................................................................................ 2
Whatarestemcells? ................................................................................................................ 2
Howarestemcellscollected? .................................................................................................. 3
Specific Section for Autologous Transplant Patients 5VeinAssessment 6WhattoExpect ......................................................................................................................... 6
G-CSFAdministration 7FrequentlyAskedQuestions-FAQs ........................................................................................ 7
TheCollectionofPeripheralBloodStemCells 9WhattoExpect ......................................................................................................................... 9
SideEffectsDuringtheApheresisProcedure ........................................................................... 9
FrequencyofStemCellCollections ........................................................................................ 10
ProcessingtheStemCellCollection ....................................................................................... 11
StorageofStemCells .............................................................................................................. 11
WhentoCalltheDoctor 11ImportantReminders 11
Phases of BMT: Autologous & Allogenic Transplants 13Pre-BMTPhase 14DiagnosticTests ...................................................................................................................... 14
Hickman®LineInsertion ......................................................................................................... 14
ConditioningTreatment .......................................................................................................... 15
BMTPhase 17TheTransplantProcess ........................................................................................................... 17
SideEffects .............................................................................................................................. 17
Post-BMTPhase 19Engraftment ............................................................................................................................ 19
Graft-Versus-Host-Disease(GVHD) ....................................................................................... 19
ManagingLowWhiteCellCounts .......................................................................................... 21
ManagingLowRedCellCounts .............................................................................................. 22
ManagingLowPlateletCounts ............................................................................................... 22
Transfusions ............................................................................................................................. 24
Discharge 24Whenarepatientsdischarged? ............................................................................................... 24
PreparationsforDischarge ..................................................................................................... 25
DischargeChecklist ................................................................................................................ 26
BMTDay100(3-Month)Evaluation 27
Introduction
WehaveputtogetherthisTransplantModuletohelppatients,theirfamiliesandcaregiverslearnabout
blood andmarrow transplantation.There aremany caring and knowledgeable peopleon your
healthcareteamtohelpyouthroughthetransplant,addressyourconcernsandansweryourquestions.
Pleasedonothesitatetospeaktothem!
Blood andmarrow transplantation is a treatment formany diseases in both adults and children. Bone
marrowisthespongytissuefoundinsideyourlargebonesandisresponsibleformakingbloodcells.These
bloodcellsincludeyourplatelets,whitebloodcellsandredbloodcells.Thebonemarrowisalsohometo
theimmunesystem.Allofthesecellsareveryimportant,soachangeinmarrowfunctioncanhaveserious
sideeffects.
Thetermbloodandmarrowtransplant,orBMT,hasbeenusedformanyyears.Youare,however,likely
tohearsomedifferentterms.Allofthesefallintothecategorycommonlydescribedasbloodandmarrow
transplant.Someofthesetermsare:
• Peripheralbloodstemcelltransplant
• Bloodstemcelltransplant
• Bloodprogenitorcelltransplant
• Bloodstemcellandbonemarrowre-infusion
Thedifferenceinthesetermshastodowithwhatisactuallytransplantedandwherethecellscomefrom.
YoucanreadmoreaboutthisinTransplantBasicsinthenextsection.
Forsimplicity,bloodandmarrowtransplant,orBMT,willbethetermusedhereforalltypesofbloodand
marrowtransplant.Aswell,thetermsbonemarrowandstemcellswillbeusedinterchangeably.
Introduction
Therearefour
typesoftransplant:•Autologous•Allogenic
•VolunteerUnrelated•Syngeneic
L/BMTPatientEducationManual•TransplantModule
Transplant Basics
Types of Blood & Marrow TransplantBloodandmarrowtransplantorBMTisusedtotreatavarietyofdiseasebutitsbasicpurposeisthesame.
BMT is used to replace amalfunctioning or non-functioning bonemarrowwith a healthy, functioning
marrow.
Before the transplant, patients undergo conditioning treatmentwith chemotherapy and/or total body
irradiation(TBI).Thisconditioningtreatmentisusedtoeliminatetheunderlyingdisease,createspacefor
thenewmarrowandpreventrejectionofthenewbonemarrow.Followingtheconditioningtreatment,
patientsundergoBMTtorestorehealthybonemarrowfunctioning.
Therearedifferenttypesoftransplantsdependingonwhodonatesthebonemarroworbloodstemcells.
Theyare:
1. Autologous Transplant. The patients donate their own stem cells prior to
treatmentforre-infusionlater.
2. Allogeneic Transplant. Stem cells are donated from an acceptably matched
familymember(usuallyabrotherorasister)oranunrelateddonor.
3. Volunteer Unrelated Transplant.Stemcellsaredonatedbysomeonewhois
notrelatedtoyou.TheanonymousdonorisfoundintheCanadianorworldwide
donorregistries.
4. Syngeneic Transplant.Thepersondonatingthestemcellsisan
identicaltwin.
YourBMTdoctorwilldiscussindetailwhattypeoftransplant
isrecommendedforyou.
What are stem cells? Bloodcellsgrowinthesamewayasotherhuman
cells.Theydevelopinthebonemarrowfroma
parentcellknownasastemcell.Stemcellsare
immaturecells thatcandevelop intoallof the
differenttypesofbloodcells:whitebloodcells,
redbloodcellsandplatelets.Stemcellsareusually
2 33
foundinsidethebonemarrowspacesoflargebones.Theycanalsotravelfromonebonetoanotherby
wayofthebloodstream.
Inabloodandmarrowtransplant,stemcellsareharvested,eitherfromthelargebonesorfromtheblood
stream,andtransplantedtothepatient.Stemcellscollectedfromthepelvicboneinthelowerbackare
calledbonemarrow.Stemcellsharvestedfromthebloodintheveinsarecalledperipheralbloodprogenitor
cells.Thisiswhybloodandmarrowtransplantsareoftenreferredtoasbloodstemcelltransplants.For
simplicity,wewillusethetermsbonemarrowandstemcellsinterchangeablyinthismanual.
YourBMTdoctorwilldiscusshowstemcellswillbecollectedfromyouoryourdonor.
How are stem cells collected?Therearetwodifferentmethodstocollectstemcells.
1.Peripheral Blood Stem Cell Collection. Stem cells can be collected from
the blood. This procedure is called a peripheral blood stem cell collection.
This technique does not require surgery. It does, however, involve a few
moresteps thanaconventionalbonemarrowharvest.Prior to thecollection,
the donor or autologous transplant patient is given amedication to promote
thegrowthandreleaseof stemcells fromthebone into theblood.Thestem
cells are then collected using a special machine called a Cell Separator. This
techniquehasdramaticallyincreasedinpopularityoverthelasttenyears.Stem
cells are generally collected using this method here at the Leukemia/BMT
ProgramofBC.
2. Bone Marrow Harvest.Stemcellscanbecollecteddirectlyfromthebonemarrow
spaces,mostoftenfromthepelvicbones.Severalpuncturesitesaremadealong
theboneandthecellsareremovedusinganeedle.Thisprocedureisknownasa
bonemarrowharvest.ThistechniqueisusedlessoftenhereattheLeukemia/BMT
ProgramofBC.
TransplantBasics2 33
Notes
L/BMTPatientEducationManual•TransplantModule 4
Leukemia / Bone Marrow Transplant (BMT)Program of British Columbia
Specific Section for Autologous Transplant
Patients
4
L/BMTPatientEducationManual•TransplantModule
Autologoustransplantreferstostemcellsorbonemarrowthatarecollectedfromthepatientand
thengivenback(re-infused)tothesameindividualinthetransplantprocess.Thisrequiresthepatient
toundergoeitherabonemarrowharvestoraperipheralbloodstemcellcollection.
Thissectionprovidesanin-depthlookatwhatis involvedinaperipheralbloodstemcellcollectionfor
autologoustransplantpatients.
Peripheralbloodstemcellcollectionforautologoustransplantpatientsinvolvesthefollowingsteps:
1.Veinassessment
2.G-CSFadministration
3.Actualcollectionofperipheralbloodstemcells
Vein Assessment
What to ExpectAveinassessmentisnecessarytoensurethatthepatienthasstrongveinswithgoodbloodflowforthe
bloodstemcellcollectionprocedure.
AnappointmentwillbemadeforyoutogototheVancouverGeneralHospitalCellSeparatorUnit,also
referredtoastheCSU.TheCSUislocatedattheKrallCentreonthe6thflooroftheCentennialPavilion.
OnyourfirstvisittotheCSU,youwillbegivenatouroftheunit.Theprocessofstemcellcollectionwill
beexplainedandshowntoyou.
Anursewillcheckyourarmveinslocatedintheelbowareatoensurethattheycanbeusedforthestem
cellcollectionprocedure.TheCellSeparatormachineneedsacertainamountofbloodflowinorderto
workproperly.Therefore,astrongveinwithgoodbloodflowisneeded.
If the veins are too small or delicate, the insertionof a temporary intravenous line called a “St Paul’s
Catheter”maybenecessary.ASt.Paul’sCatheterisasmallplastictubethatisplacedintoalargevein
locatedinthesideoftheneck.Sometimesitisnecessary(butrare)toplacetheSt.Paul’sCatheterinthe
largegroinvein,whichdrainsthebloodfromthelegs.Thistubeallowsthebloodtobeeasilyremovedand
returnedtoyourbody.IfyourequireaSt.Paul’sCatheter,thenursewillmakeanappointmentforyouwith
theAngio-RadiologyDepartment.TheSt.Paul’sCatheterwillbeinsertedthedaybeforeorthedayofthe
stemcellcollection.Thecatheterwillberemovedafterthecollectionsarecompleted.
ThenursesanddoctorsattheCSUwishtomakethecollectionexperienceasstress-freeandcomfortable
aspossible.Pleaseletthemknowifthereisanythingtheycandotoassistyouinthis.
6 77
G-CSFisavery
expensiveprescriptionmedicationandisnot
paidforbytheVancouverGeneralHospitalortheBC
CancerAgencyfortheautologoustransplantpatient.Unfortunately,thisistheonlymedicationthatcanbeusedtoincreasebloodstemcells.Generally,thecostofG-CSFforonecourseoftreatmentisbetween$3,000.00and
$3,800.00.
G-CSF Administration
Frequently Asked Questions - FAQs
What is G-CSF?
G-CSFisacolonystimulatingfactor.Colonystimulatingfactorsarenaturallyoccurringspecialproteinsin
thehumanbodythatstimulatebloodcellproductionandgrowth.G-CSFhelpsincreasethenumberof
stemcellsinyourbloodstream.
Thesenaturallyoccurringproteinscanalsobemanufacturedasadrug.TheG-CSFusedinourProgramis
Neupogen®.Thegenericnameisfilgrastim.
Why is G-CSF given?
Inordertolimitthenumberoftimesyouhavetoundergostemcellcollection,
theBMTdoctorwilltrytomoveyourstemcellsoutofyourbonemarrow
and into your blood stream. This process is calledmobilization.
TheG-CSF youwill receive will encourage the growth of stem
cells in your body andmobilize them into your blood stream
forcollection.
How will it help my transplant?
Engraftmentistheprocessbywhichre-infusedstemcells
grow in the bone marrow and manufacture new blood
cells.After your stemcells are re-infused, engraftment is
theindicationthatthenewstemcellsareworkingproperly.
Researchhasshownthatstemcellsthathavebeenmobilized
engraft faster than stem cells collected directly from the
bonemarrow.
How much does G-CSF (Neupogen®) cost?
G-CSFisaveryexpensiveprescriptionmedicationandisnotpaid
forbytheVancouverGeneralHospitalortheBCCancerAgency
for the autologous transplant patient.Unfortunately, this is the only
medicationthatcanbeusedtoincreasebloodstemcells.Generally,the
costofG-CSFforonecourseoftreatmentisbetween$3,000.00and$3,800.00.
SpecifictoAutologousTransplantPatients6 77
Otherdrugsmayinteractwith
G-CSF.Itisimportantthatyoutellyourdoctorifyouaretakinganyothermedications.Thisincludesover-the-counterdrugs,naturopath/herbalremedies,vitamins,
teas,etc.
L/BMTPatientEducationManual•TransplantModule
Hereiswhatyouneedtoknow:
1.YoushouldberegisteredforBCFairPharmaCare.YoucancontactFairPharmaCare
(1-800-663-7100)toclarifyyourbenefitplanandmedicationcoverage.Ifyouhave
already reachedyourdeductible amountwithFairPharmaCare, in thepresent
calendaryear,thecostofyourG-CSFmaybegreatlyreduced.
2.DependingonyourextendedhealthplanandyourFairPharmaCaredeductible,
youwillneedtopayforsomeorthisentireamount“out-of-pocket”.
3.You may have drug cost reimbursement through an extended health plan or
fundingfromsocialassistance(MinistryofHumanResources).Youshouldcontact
the insurance carrier or your financial aid worker to discuss coverage of this
medication.
4.Ifyouhavetriedalltheaboveandstillcannotaffordthemedication,pleasecontact
theL/BMTCoordinatorortheL/BMTSocialWorkerassignedtoyou,todiscuss
thissituationfurther.
How is G-CSF given?
G-CSFwillbeadministereddailyby injectionthroughatinyneedleundertheskin.Arrangementswillbe
madeforyoutoreceiveyourinjectionseitherintheCellSeparatorUnit,theL/BMTDaycareUnitorifyou
preferyoumayarrangetohavethemgivenatyourfamilydoctor’sofficeorwalk-inclinicnearyourhome.
Generally,youwilltakeG-CSFfor5days.Stemcellcollectionwillcommenceonthe4thday.Onthe5thday
youwillhaveanearlyappointmenttocometotheCellSeparatorUnit(CSU)andhaveyourblooddrawn
inordertocheckyourbloodcounts.Assumingyourneutrophilcountissufficientlyhigh,
youwillproceedtohaveyourperipheralstemcellscollected.Ifyourcountsarenot
elevatedenough,youmaybeprescribedadditionaldaysofG-CSFtherapy.
What should I expect when injecting G-CSF?
When G-CSF is injected, you may feel a slight stinging sensation at the
injectionsite.Sometimes, injecting intoa largersurfaceareasuchas the
abdomenorinjectingthemedicationslowercanreducethestinging.Ifyou
experiencesomepainorrednessattheinjectionsite, itshouldgoaway
soon.Ifitdoesnot,contactyournurseordoctor.
Sometimesa“bump”occursattheinjectionsite.Do not rub it.Thebump
willoftengoawaywithinafewhours.Ifthebumppersistsformorethana
fewhours,contactyournurseordoctor.
8 99
Asmallamountofmedicationcansometimesleakoutattheinjectionsitewhentheneedleiswithdrawn.
Ifitdoes,simplyapplylightpressurewithanalcoholswab,butdonotrubthearea.
OtherdrugsmayinteractwithG-CSF.Itisimportantthatyoutellyourdoctorifyouaretakinganyother
medications.Thisincludesover-the-counterdrugs,naturopath/herbalremedies,vitamins,teas,etc.Inform
yourdoctorevenifyouonlytaketheseoccasionally.
What are the side effects of G-CSF?
Generally,G-CSF iswell tolerated.Somepatientshaveexperienceddiscomfortthat isusuallyreported
asheadacheand/oraching inthebones,mostoften inthebackandhips. Ifyoufeeldiscomfort,please
contactyourdoctorornurseforadviceonhowbesttorelieveit.Besuretotellyournurseordoctorif
youexperienceanysymptomsthatconcernyouwhileyouaretakingG-CSF.Nevertakeamedicationfor
asideeffect,orforanythingelse,unlessyournurseordoctorrecommendsit.
The Collection of Peripheral Blood Stem Cells
What to ExpectYourstemcellswillmostlikelybecollectedbyaprocedurecalledapheresis(a-fair-ee-sis).Twoendsof
tubingwillconnectyoutoacellseparatormachineduringthecollection.Yourbloodwillflowoutofone
arm,insidethetubing,tothemachinewhereitwillspinyourbloodaroundathighspeed.Thespinning
separatesthedifferentcomponentsofthebloodintolayersbasedontheirweight.Thestemcelllayerwill
thenbecollectedandtheremainingbloodwillbereturnedtoyouviatheotherarm.Thebloodalwaysstays
insidethetubingset.Thetubingandneedlesaresterile.Theyareusedonlyonceandthendiscarded.
Youwillbeattachedtothecellseparatormachinefor4–6hoursforeachcollection.Therewillbenurses
andtechnicianspresentfortheentiretime.Duringtheprocedureitisnecessaryforyoutostayinbed.
Eachbedareahasatelevisionsettohelpyoupassthetime.Youmayalsohaveafriendstaywithyou.
Side Effects During the Apheresis ProcedureTheapheresisprocedureissafe.However,therearesomesideeffectsyoumayexperienceandshould
beawareof:
• IfyouhaveanIV(intravenous)needleintheinsideelbowregionofyourarm(s)
youwillneedtokeepyourarm(s)straightduringtheprocedure.Sometimesthis
canbeuncomfortable.Pleaseletthenursesknowsothattheycanassistyouin
gettingascomfortableaspossible.
SpecifictoAutologousTransplantPatients8 99
Youmaystarttofeellight-
headed,nauseated,coldorexperiencemusclecrampingortinglingaroundthelips,handsorfeet.Tellthenursesimmediately.
L/BMTPatientEducationManual•TransplantModule
•Theflowofbloodfromyourveinscansometimesbeslow
andvariable.Inthiscase,thenursesmayaskyoutosqueeze
your hands to increase blood flow, change your arm
position,orthenursesmayadjustthelinesormachine.
Occasionallyaneedlewillhavetobereplacedinorderto
getbetterbloodflow.
• Changes in blood volume may make some people
feel dizzy or light-headed. You should tell the nurses
immediatelyifyoufeelanythinglikethis.
•Ananticoagulant(anti-clotting)drugismixedwithyour
bloodasitentersthemachinetokeepitfromclottingduring
the procedure. Thismay cause a sour taste in yourmouth.
Theanticoagulantcanalsoloweryourbloodcalciumandyoumay
experiencelight-headedness,nausea,musclecramping,and/oratingling
feelingaroundthelips,handsorfeet.Youshouldtellthenursesimmediatelyifyou
feelanyofthesesymptoms.Oralorintravenouscalciumwillbringquickreliefof
thesesideeffects.
•Youmaystarttofeelcoldduringtheprocedure.Ifyoufeelchilled,pleaseletthe
nurses know.They can give you extra blankets and heating pads to keep you
warmandcomfortable.
Frequency of Stem Cell CollectionsThegoal is tocollectenoughcells foroneortwotransplantsdependingonwhyyouarereceivingthe
transplant.Yourphysicianwill havediscussed thiswithyouprior toyour treatment.The targetedcell
collectionisusuallyachievedin1to2days.Occasionallyathirddayofcollectingisrequired.Thenumber
ofstemcellcollectionsneededlargelydependsonthepatient’sweightandresponsetotheG-CSFandthe
apheresisprocedure.
Immediatelyaftertheapheresisprocedureiscompleted,specimensareobtainedfromthebagofcollected
stemcells.Thesearesentassoonaspossibletoaspeciallabwherethesamplewillbestudiedandthe
actualstemcellcountwillbedetermined.Resultsofthisanalysiswillusuallybecompletedby4:00pmthat
sameday.Oncetheactualcountisknownandreviewedbythedoctor,youwillbenotifiedastowhether
morestemcellcollectionsareneededonsubsequentdays.
10 1111
When to Call the Doctor
•Haveafeverof38°C(100°F)orhigher
•Havechills
•Developarashorsymptomsofanallergicreaction
•Painwhenurinating
•Arebleeding, orhaveaproblemsuchasalump,
swellingorbruisingattheinjectionsitethat
doesn’t goaway
•Noticeanythingunusualaboutyourcondition
Processing the Stem Cell CollectionInordertopreservethestemcells,theywillneedtobefrozen.Thisprocessiscalledcryopreservation.
Shortlyafterthestemcellsarecollected,theyaresenttoaspeciallabcalledtheCryogenicsLab.There,
thestemcellswillbeconcentratedandapreservativewillbeaddedtoprotectthecellsfromthefreezing
process.Theywillthenbestoredinaspecialfreezingvaultuntilthetimeyou
needthem.
Storage of Stem CellsUnder the new policy, stem cells older than 7 yearswill be discarded or
donated to the Canadian Blood Services with the patient’s consent and
knowledge.Thequalityofthestemcellaftersuchalongperiodofstorageis
uncertain.YourBMTdoctorwilldiscussthisindetailwithyou.
When to Call the DoctorNeverhesitatetocallthedoctorornurseifyouhaveanysymptomsthatworryyou
orifyouareconcernedwithanyaspectofyourtreatment.However,contactthe
doctorornurseimmediatelyifyou:
•Haveafeverof38°C(100°F)orhigher
•Havechills
•Developarashorsymptomsofanallergicreaction
•Painwhenurinating
•Arebleeding,orhaveaproblemsuchasalump,swellingorbruisingatthe
injectionsitethatdoesn’tgoaway
•Noticeanythingunusualaboutyourcondition
Important RemindersThingstokeepinmind:
1.TheCellSeparatorUnit(CSU)canbereachedat604-875-4626.
2.AppointmenttimesforstemcellcollectionsattheCSUareusuallybetween
8:00amand9:00am.
SpecifictoAutologousTransplantPatients10 1111
Itisveryimportantthat
youhavebreakfastbeforecomingtothe
unit, preferablyonethatis richincalcium.
TheCSUcanbe reachedat
604-875-4626.
L/BMTPatientEducationManual•TransplantModule
3.Theentireprocesscantakeupto4–6hoursfromstarttofinish.Thismakesfora
verylongday.Youmaywishtobringyourownlunchandsnacks. TheCSUcan
provide ju ice, cookies anda l imitedse lect ionofsandwiches.
4.ItisItveryimportantthatyouhavebreakfastbeforecomingtotheunit,preferablyone
thatisrichincalcium.
5.Donotdrinkcoffeeorteabeforetheprocedure,asyouwillnotbeabletoget
uptousethewashroomonceyouarehookeduptothecellseparator
machine.
6.Pleaseusethewashroomfacilities intheCSUjustbefore
theprocedurebegins. If youneed togo to thebathroom
duringtheprocedure,bedpansareavailable.Anursewill
help you with this. It is recommended that you wear
comfortableandloosefittingclothing(i.e.,pantswithan
elasticwaistbandmaymakethingseasier).
7.Youwillhaveyourowntelevisionavailableforyouruse
during theapheresisprocedure.Also,unlessyouhavea
St.Paul’sCatheter,readingmaterialswouldbeinappropriate
tobring,asyouwillnothavetheuseofyourarms.
8.Once the procedure has started, the nurseswill allowone
visitortostaywithyou.
9. It is very important to notify the nurses right away if you feel light-
headed,dizzy,nauseated,cold,orhavetinglingaroundthelips,fingersortoes,during
theprocedure.Slowingorstoppingtheprocedureforashorttimecansometimes
resolvesomeofthesesymptoms.
12
Autologous & AllogenicPhases of BMT:
Transplants
Leukemia / Bone Marrow Transplant (BMT)Program of British Columbia
12
Autologousandallogeneic
bloodandmarrowtransplantsusuallyfollowthesefour
phases:
1.Pre-BMTPhase
2.BMTPhase
3.Post-BMTPhase
4.Discharge
L/BMTPatientEducationManual•TransplantModule
Autologous and allogeneicbloodandmarrowtransplantsusuallyfollowthese
fourphases:
1.Pre-BMTPhase
2.BMTPhase
3.Post-BMTPhase
4.Discharge
Pre-BMT Phase
Diagnostic TestsManydiagnostictestsaredonepriortohavingabloodandmarrowtransplant.Somepatientswillhave
thesetestscompletedbeforetheyareadmittedtohospital.Otherswillhavethetestscompletedsoon
afteradmission.Thiswilldependupontheadmissiondateandtheschedulethathasbeensetupforeach
patient.TeststhathavetobecompletedonmostpatientspriortoaBMTare:
•Bloodtests,includingtestingforexposuretohepatitisandHIV(theAIDSvirus)
•Bonemarrowbiopsy
•Chestx-ray
•Dentalx-ray
•Electrocardiogram(ECG)
•Aheartfunctionstudy(RVG)
•Lungfunctiontests(PFTs)
Tolearnmoreaboutthesetests,refertoDiagnosticTests&ProceduresintheCoreModule.
Hickman® Line InsertionItisalsoduringthePre-BMTPhasethataspecialintravenouslineknownasaHickman®linemaybeinserted.
TheHickmanline®isanintravenousdevicethatisusedtogivefluids,bloodtransfusions,medications,and
thebloodstemcellsduringthere-infusionprocess.Somepatientsmayalreadyhaveacentralvenousline
whentheyareadmittedtothehospital.OtherswillhavetheirHickman®lineinsertedwithin1–2daysof
admission.
To learnmoreabouttheHickman® line insertionprocedure,refertoDiagnosticTests&Procedures in
theCoreModule.
14 1515
Conditioning Treatment
What is conditioning treatment?
Conditioningtreatmentisusedtoeliminatetheunderlyingdisease,createspaceforthenewmarrowand
preventrejectionofthenewbonemarrow.
Once theconditioning treatmenthasbegun,patientsusuallyneed tobe inprotective isolation tohelp
preventinfection.Protectiveisolationmeansthatitisnecessaryforthepatienttoremaininthehospital
roomorwardmostofthetime.However,therearecircumstanceswhenpatientsmustleavethehospital
roomorwardtohavetests inotherdepartments.Protective isolationcontinuesthroughouttransplant
andforaboutthreeweeksposttransplant,untilthepatient’sconditionandwhitebloodcellcounthave
improvedtoasatisfactorylevel.
Types of Conditioning Treatment
There is a variety of conditioning regimens that involve chemotherapy alone, or a combination of
chemotherapyandtotalbodyirradiation(TBI).YourBMTdoctorwillprovidedetailedinformationabout
theparticularconditioningtreatmentthatisrecommendedforyou.
1.Chemotherapy. All patients will receive chemotherapy drugs prior to the
bloodandmarrowtransplant.Thechemotherapyisgiveninhighdosesinorder
to eliminate the disease or cancer. In the case of an allogeneic (donor) BMT,
chemotherapy suppresses the immune system to allow the transplanted bone
marrowtoundergoaprocesscalledengraftment.Chemotherapyisadministered
byanurseinthepatient’shospitalroomthroughtheHickman®line.Yourphysician
willdiscussthepossiblesideeffectsofchemotherapyindetailwithyou.
To read more about chemotherapy agents and the possible side effects and
complicationsfromchemotherapyagents,refertotheChemotherapyModule.
2. Total Body Irradiation (TBI). Somepatientswill receive radiation therapy in
additiontochemotherapyduringtheirconditioningtreatment.Likechemotherapy,
totalbodyirradiation(TBI)isusedtoeliminatethediseaseandinthecaseofallogeneic
(donor)transplant,tosuppressthepatient’simmunesysteminpreparationforthe
transplantedstemcells.TBIisgivenintheRadiotherapyDepartmentattheBritish
ColumbiaCancerAgency.BeforereceivingTBI,patientsgototheRadiotherapy
Departmentforapre-treatmentappointment.Thepurposeofthisappointment
is to take specialmeasurements of height,weight, and body thickness so that
theradiationtreatmentscanbetailoredtoeachindividualpatient.Anumberof
specialmarkingsareplacedontheskinatthistimetoserveaslandmarkswhen
PhasesofBMT•Pre-BMTPhase14 1515
Notes
L/BMTPatientEducationManual•TransplantModule
thetreatmentbegins.Thisplanningappointmentisanexcellenttimetomeetthe
staffintheRadiotherapyDepartmentandtoaskanyquestions.Wesuggestthat
youwriteyourquestionsdownandbringittoyourappointment.
Toreadmoreabouttotalbodyirradiationandpossiblesideeffectsandcomplications,
refertotheChemotherapyModule.
16 1717
Mostpeople
aresurprisedthattheactualinfusionofstemcellsisaverystraightforwardprocedure.
BMT Phase
The Transplant Process
What actually happens in the transplant?
Oncetheconditioningtreatmentiscompleted,youarereadytoreceivethedonor’s
oryourownbloodstemcells/bonemarrow.TheBMTPhaseistheshortestphase.
Theprocessconsistsoftheinfusionofthestemcells.Atthispoint,patientsareoften
relievedthattheconditioningtreatmentisover,andexcitedbythefactthatthetransplantcan
nowtakeplace.Thedayofyourtransplantwillbereferredtoas“Day0”.
Mostpeoplearesurprisedthattheactualinfusionofstemcellsisaverystraightforwardprocedure.The
stemcellsenterthepatient’sbloodstreamthroughtheHickman®line.Muchlikeabloodtransfusion,the
stemcellinfusionprocesstakesanywherebetween20minutestoacoupleofhours.
Anursewillbeintheroomfortheentiretransplantandadoctorwillbepresentforthebeginningandthen
availableontheunitfortheremainderofthetransplant.
Side EffectsPatientsdonotgenerallyexperienceanysignificantsideeffectsfromtheactualstemcell/bonemarrow
infusion.Somepeopledevelopchills,rashes,afastpulserate,orhighbloodpressure.However,eachof
thesesymptomsiscarefullymonitoredandtreatedasnecessary.
Anursewillbeintheroomfortheentiretransplantandadoctorwillbepresentforthebeginningandthen
availableontheunitfortheremainderofthetransplant.
Specific to Autologous Transplant
Ifyouareundergoinganautologoustransplant,i.e.,receivingyourownstemcells,yourstemcellswould
havetobefrozenandthenthawedpriortothetransplant.Toprotectthestemcellswhiletheyarefrozen,a
preservativecalledDMSO(DimethylSulfoxide)isused.Duringandafterthetransplant,youmayexperience
somesideeffectsfromDMSO.
TheDMSOmaycauseyoutohaveagarlic-like(oroyster/creamofcorn-like)tasteinyourmouththatwill
lastafewdays.Somepatientsfinditbeneficialtochewgumorsuckonhardcandiestolessenthiseffect
duringtheinfusion.Occasionally,DMSOcancausenausea,shortnessofbreath,wheezing,stomachpains,
loweredheartrate,orallergicreaction.Youwillbegivenmedicationbeforethetransplanttohelpprevent
PhasesofBMT•BMTPhase16 1717
Notes
L/BMTPatientEducationManual•TransplantModule
themfromoccurring.AlthoughnotduetoDMSO,yoururinemaybecomered-colouredfor24hoursafter
theinfusion.Anursewillbeinyourroomduringtheentiretransplanttomonitoryouclosely.Adoctorwill
bepresentforthebeginningandthenavailableontheunitfortheremainderofthetransplant.
18 1919
Itisduringthe
Post-BMTPhasethateveryonelooksforwardtoevidencethatthetransplantedstemcellshavetravelledtotherightplaceandarestartingtowork.
Post-BMT Phase
Engraftment
What is engraftment?
ThePost-BMTPhaseisthelongestphaseofabloodandmarrow
transplant.Itbeginsfollowingthestemcell/bonemarrowinfusion,
andcontinuesthroughouttherecoveryperiod.
ItisduringthePost-BMTPhasethateveryonelooksforwardtoevidencethat
thetransplantedstemcellshavetravelledtotherightplaceandarestartingtowork.Engraftmentisthe
processinwhichthetransplantedstemcellsfindtheirwaytothebonemarrowspacesinthecentreofthe
largebonesofthebody.Onlythencanthetransplantedstemcellsbegintoproducenewbloodcells.
Expertsarenotcompletelycertainhowthisamazingprocesshappens.Ittakesapproximatelytwotofour
weeksafterthestemcell/bonemarrowisinfusedforengraftmenttooccur.
Thereareseveralwaysthatyourdoctorcantellthatengraftmenthasbegun.Thefirstsignofengraftment
isthegradualriseofwhitebloodcellcountorplateletcountthatbeginsabouttwoweeksafteryourBMT
day.Redbloodcellsoftentakealittlelongertobegindeveloping.
Graft-Versus-Host-Disease (GVHD)Graft-versus-hostdiseaseorGVHDisatermusedtodescribeabattlebetweenthetransplantedstemcells
andthepatient’sbody.Thisisacomplicationthatoccurswhenthenewstemcells(thegraft)rejectorsee
yourbody(thehost)asforeign.
WhileGVHDisextremelyrareinautologoustransplants,itoccursinapproximately50%ofpatientswho
haveanallogeneic(donor)transplant.GVHDislesslikelytooccurifthedonorandrecipientarematched–
haveidenticaltissueor“HLA”types.Theconditionisconsiderablymorecommonwhenthematchisonly
partialorifthedonorandrecipientareunrelated.Allpatientsreceivingbonemarrowfromadonor,unless
thedonorisanidenticaltwin,willreceivedrugstotrytopreventGVHD.
Of thosewhodevelopGVHD,manywill experienceonlyminordifficulties.Abouthalfwill experience
significantproblems.TherearetwotypesofGVHD:acuteandchronic.
Acute GVHD
AcuteGVHDmayoccurearlywhenthebonemarrowstartstoengraftaroundtwotofourweeksafterthe
transplant.AcuteGVHDmayinvolvethreemainbodysystems:
PhasesofBMT•Post-BMTPhase18 1919
GVHDisnotalwaysanegative
developmentfollowingabloodandbonemarrowtransplant.ThisisbecausetheimmunesystemthatattacksthehostcausingGVHDisalsoknowntoattackcancercells.ResearchershavefoundthatpatientswithGVHDgenerallyhave
alowerriskofhavingarelapseoftheircancer.
L/BMTPatientEducationManual•TransplantModule
1.Skin GVHDusuallyshowsupasarashanywhereontheskinsurfacebut it is
mostlyseenonthehands,feet,abdomenandface.Theskin initially lookssun-
burnt.Therashmayprogresstootherareasofthebodyandpotentiallybecome
ablister-likerash.
2. Liver GVHDbecomesevidentinyourbloodwork.Bloodworkisdoneregularly
to test how your liver is functioning.With liverGVHD, these results become
elevated.LiverGVHDmayalsocausethepatienttobecomejaundiced(tohavea
yellowtonetotheskin).
3. Gastrointestinal Tract GVHD appears as nausea and vomiting and/or acute,
watery or sometimes explosive diarrhea. The amount of diarrhea can indicate
theseverityoftheGVHD.Anexamofthegastrointestinal tract isalsodoneto
confirmGVHD.
Chronic GVHD
ChronicGVHDoccursafter100dayspost-BMT.ItmaydevelopasacontinuationofacuteGVHDoroccur
without anypriorhistoryof acuteGVHD.ChronicGVHD isusually less serious. It ismost frequently
associatedwithsorenessordrynessofthemouthoreyes,lungandlivercomplications,changesinskin
pigmentation.Itmayalsocausehairloss,weightloss,vaginaldryness,cough,shortnessofbreathandjoint
problems.
Management
TomanageandtreatGVHD,anumberofdrugssuchascyclosporine,methotrexateandprednisoneare
usedearlyontohelppreventorminimizeGVHD.However,somesideeffectsofthedrugscaninterfere
withthepatients’qualityoflife.YourBMTdoctorwilldiscussthesewithyouindetail.
GVHD is not always a negative development following
a blood and bone marrow transplant. This is
becausetheimmunesystemthatattacks
thehostcausingGVHDisalsoknown
toattackcancercells.Researchers
have found that patients with
GVHD generally have a lower
risk of having a relapse of
theircancer.
20 2121
Infection –if any of these
symptoms appear, notify your nurse or
doctor immediately
• Fever of greater or equal to 38°C
(Celsius) or 100°F (Fahrenheit)
• Skin tenderness • Chills/sweating
• A burning feeling when urinating • Rectal pain/
tenderness • A cough, sore
throat or mouth pain
Managing Low White Cell Counts
Overview
Inahealthy individual,whitebloodcellsprovideprotection
against infections caused by bacteria, viruses and fungi.
There are several different types of white blood cells, but
neutrophils are the most common type. Neutrophils fight
infectionby rapidly increasing innumberwhenan infection
occurs.Theythensurroundanddestroythe infection.Your
“absoluteneutrophilcount”(ANC)ismonitoredcloselyafter
yourtreatmenttogiveusanindicationofyourabilitytofight
infectionandtoindicatethebeginningsofengraftment.
Afterreceivingyourtransplant,yourwhitebloodcellcount
willdecreasequicklyandwillremainlowuntilthenewcells
begin to grow (engraftment). During this time, you are at
greatriskfordevelopinganinfectionsinceyouwillnothave
whitebloodcellstofightbacteria,virusesorfungi.Although
theriskofinfectiondecreasesastheimmunesystemrecovers
(whitebloodcellcountrises),BMTpatientsmustcontinueto
takeprotectivemeasures until their bonemarrowhas fully
recovered.Recoveryonaveragetakes6–12monthsafterthe
transplant.
Precautions Against Infections
Many precautions are taken to prevent infection in bone
marrow transplant patients. For example, the protective
isolation procedures and guidelines for visitors are for the
purposeofpreventinginfectionwhileyouareinhospital.For
acompleteguidelineonhowtoprevent infections, refer to
YourResponsibilitiesintheCoreManual.
Signs of Infection & Management
Oneofthemostcommonsignsofinfectionisafever.MostBMT
patientswillhavean increase intemperaturethatmaysignalan
infectionatsomepointduringtheirtransplantexperience.Infections
PhasesofBMT•Post-BMTPhase20 2121
L/BMTPatientEducationManual•TransplantModule
canoccuratanytimepriorto,during,andafterthetransplant.Becauseallpeoplecarrygerms(organisms)
intheirsystemsnaturally,infectionsinthetransplantpatientareoftenfromthepatient’sownorganisms.
Althoughinfectionscanbequiteserious,therearemanyapproachestotreatment.Anti-bacterial,anti-viral
andsometimesanti-fungalmedicationsareprescribedduringthePost-BMTPhasetotreatthesedifferent
typesofinfection.
Tohelpidentifyanearlyinfection,itisimportanttoletthehealthcareteamknowhowyouarefeeling.
Somesymptomsofaninfectionare:
• Feverofgreaterorequalto38°C(Celsius)or100°F(Fahrenheit)
• Skintenderness
•Chills/sweating
•Aburningfeelingwhenurinating
• Rectalpain/tenderness
•Acough,sorethroatormouthpain
Ifanyofthesesymptomsappear,notifyyournurseordoctorimmediately.
Managing Low Red Cell Counts
Symptoms & Management
Redbloodcellscontainhemoglobinwhichcarriesoxygenfromthelungstoallofthetissuesinthebody.
Thisiswhatgivesusourenergy.Afteryoureceiveyourtransplant,yourredbloodcellcountwilldecrease
quicklyandwillremainlowuntilthenewcellsbegintogrow.
Whenredbloodcellsarelow,patientsbecomesanemicandmayfeelquitetiredandshortofbreathas
aresult.Othersymptomsmayincludedizzinessandfeelingchilled.Untilthetransplantedbonemarrow
startsmakingenoughredbloodcellsonitsown,youwillrequireredbloodcelltransfusionstomaintain
yourredbloodcellcount.Generally,whenyourhemoglobincountdropsbelow80,youwillreceivepacked
(concentrated)redbloodcells.Somepatientsmayrequirethemsooner.
Toreadmoreabouttransfusions,gotopage24.
Managing Low Platelet Counts
Overview
Platelets(thrombocytes)aretinybloodcellparticlesthathelpformclotsandpreventbleeding.Theydoso
bystickingtothesiteofabloodvesselinjury,clumptogether,andsealofftheinjuredbloodvesseltostop
bleeding.Whenplateletsarelow,youaremoresusceptibletobleeding.Somesignsandsymptomsthatmay
22 2323
Pleasenotifyyournurseordoctorofthefollowing:
1.Bruising
2.Bleedingwounds
3.Bloodinyoururineorstool
4.Bleedinggumsornose
5.Bloodinanymucous/sputum thatiscoughedup
6.Smallpinpointredorpurplespots underyourskin(petechiae)
occurwithlowplateletcountsincludebleedinggums,bruisingandnosebleeds.Urineandbowelmovements
willbecheckedforsignsofbleedingonaregularbasis.Becauseexcessivebleedingmayoccurduringmonthly
menstrualperiods,womenmayreceivespecialmedicationstopreventbloodlossinthisway.
Precautions Against Bleeding
Whileyourplateletsarelow,therearesomeprecautionsyoucantaketopreventbleeding:
1.Takegoodcareofyourskinandlips,asdrynessmayleadtocracksandbleeding.
2.Useonlyasofttoothbrush.Donotscrubyourgums
vigorously.
3.Avoidblowingorpickingyournose.
4.Useonlyanelectricrazor.
5.Wear shoes or slippers at all timeswhen
youareoutofbed.
6.Exercisebywalkingorridingastationary
bike. Avoid rough activity or exercises
thatmaycauseyoutoinjureyourhead
orotherpartsofyourbody.
Symptoms & Management
If your platelet count drops below “10” or you
havebleedingissues,youwillneedatransfusion.Your
plateletcountmaybecheckedasoftenaseverydayand
youwillbewatchedforsignsofbleeding. Pleasenotifyyour
nurseordoctorofthefollowing:
1.Bruising
2.Bleedingwounds
3.Bloodinyoururineorstool
4.Bleedinggumsornose
5.Bloodinanymucous/sputumthatiscoughedup
6.Smallpinpointredorpurplespotsunderyourskin(petechiae)
Until the transplanted stem cells start making enough platelets, you will require platelet transfusions.
Platelettransfusionsmayalsobenecessaryforaperiodoftimeafterdischargefromhospital.
PhasesofBMT•Post-BMTPhase22 2323
L/BMTPatientEducationManual•TransplantModule
Transfusions
Overview
Youmayrequireblood(redcells)and/orplatelettransfusionsfrequentlyduringyourtreatment.Withall
transfusionsthereisthepotentialofhavingatransfusionreaction.Becauseofthis,thebloodproductis
irradiatedandleuko-reduced(whitecellreduced)todecreasethelikelihoodofatransfusionreaction.If
youhavehadatransfusionreactioninthepast,pleaseinformyournurseordoctor.Ifatanytimeduringor
afteratransfusionyoufeelwarmorchilled,haveshortnessofbreath,aredizzy,noticehives(bumps/welts
onyourskinsimilartogiantmosquitobites)orifyourskinitches,notifyyournurseimmediately.
Where does donated blood come from? Is it safe?
Wholeblood is collectedbyCanadianBlood Services fromvolunteer donors.All potential donors are
screenedbyawrittenquestionnaireandinterviewedbyanurse.Thedonatedbloodisprocessedintoits
separatepartsandtestedfor:
1.HepatitisB
2.HepatitisC
3.HumanImmunodeficiencyVirus(HIV1and2–theAIDSviruses)
4.HumanT-CellLymphotripicVirus1and2
5.Syphilis
6.WestNileVirus(summertimes)
Ifthebloodisfoundtohaveanyoftheseinfections,itisdisposedofandneverused.Bloodisnevercollected
fromthisinfecteddonoragain.However,youneedtobeawarethatbloodcanneverbeguaranteedtobe
100%safe.Yourdoctorwilldiscussthisfurtherwithyoupriortoyourfirsttransfusion.Youwillneedto
signabloodproductconsentformbeforereceivinganybloodproducts.
Toreadmoreaboutthebloodtransfusionprocedure,refertoDiagnosticTests&ProceduresintheCoreModule.
Discharge
When are patients discharged?
Criteria for Discharge
Patientsreceivingatransplantcanusuallyexpecttobeinhospitalforatleastthreeweeks.Thehealthcare
teamensuresthatyouarestableenoughtopermitmonitoringasanoutpatientbeforedischargingyou.
24 2525
PlantostayintheVancouver
areaforseveralweeksafteryouaredischarged.Theremaybesomeexceptionstothisrule;however,youshouldbeawareofthisandmakethenecessaryarrangements
withoutdelay.
Afewcriteriathatneedtobemetpriortodischargeare:
•Bloodcellcounts(whitecells,redcellsandplatelets)havereachedasatisfactory
level.Youmaystillneedbloodproducttransfusionsasanoutpatient.
•Therearenocomplicationspresentthatwouldstopyoufrombeingmonitoredas
anoutpatient.
• Yourstatusisstableenoughtopermitmonitoringonanoutpatientbasis.
• You are able tomaintain adequate fluid intake and eat a satisfactory dietwith
sufficientcaloriestomaintainweight.
• Youhavesufficientstrengthandmobilitytoattendregularclinicvisits.
• YouoryourcaregiverisabletocareforyourHickman®line.
• Youareabletotaketherequiredmedications.
• Youhaveasuitableplacetolive,preferablywithin45minutesofthehospital,while
attendingtheOutpatientDaycareUnit.
Preparations for DischargePlantostayintheVancouverareaforseveralweeksafteryouaredischarged.Theremaybesomeexceptions
tothisrule;however,youshouldbeawareofthisandmakethenecessaryarrangementswithoutdelay.
ThisisnecessarysoyourprogressmaybemonitoredcloselyintheLeukemia/
BMTDaycareOutpatientUnit.
Beforeyouaredischarged,theclinicalpharmacistwillseeyou.
Theywillthoroughlydiscussyourdischargemedications
withyoubeforeyouleave.Theywillreviewwithyou
thepurposeofeachmedicationaswellasthedose,
time,special instructionsandmajorsideeffectsand
drug interactions. The pharmacist will provide you
with amedication calendar to help you keep track.
Keepitwithyouatalltimes.
IfyouaretakingcareofyourownHickman®lineathome,
thenursewillprovideyouwithasupplykitunlesstheHickman®
lineistoberemovedshortlyafteryourdischarge.
PhasesofBMT•Discharge24 2525
L/BMTPatientEducationManual•TransplantModule
Discharge ChecklistBeforeyouaredischargedfromtheLeukemia/BMTInpatientUnit,pleasemakesurethattheitemsinthe
DischargeChecklisthavebeencompletedordiscussedwiththenurseordoctor.
Hickman® Line Care
IcanchangemyHickman®linedressingindependently.
Ineedmorehelplearningdressingchanges.
Icanflushthelineandchangethecapsindependently.
Ineedmorehelplearningflushingandcapchanges.
MyHickman®linekithasbeenpickedupfromtheBCCAPharmacy.
Icandrawbloodspecimens.
Ihaven’tlearnedtodrawbloodspecimensyet.
Icandointravenousinfusions:priming,starting,discontinuing.
Ihaven’tlearnedtodointravenousinfusionsyet.
Medications
Ihavereceivedmyprescriptions.
Iknowwheretohaveeachprescriptionfilled.
Iknowhowandwhentotakemymedications.
Ihaveanorganizingsystemformymedications.
Iknowwhatmymedicationsareforandthemajorsideeffectsanddruginteractions.
IknowwhotocallifIhaveanyquestions.
Monitoring for Complications
IhaveaCelsiusthermometertouseathomeafterdischarge.
Iknowwhatsignsandsymptomstoreportimmediately.
Iknowwhotocalltoreportsignsandsymptoms.
Iknowwhotocallforassistanceinanemergency.
Follow-Up at Leukemia/BMT Daycare Unit
IknowthedateandtimeofmyfirstCP6OutpatientDaycareUnitappointment.
IknowwheretheBMTDaycareUnitislocated.
IhavereadthesectiononOutpatientUnit:Leukemia/BMTDaycareintheCoreModule.
Ifapplicable,accommodationintheLowerMainlandhasbeenarrangedformydischarge.
26 2727
Notes
BMT Day 100 (3-Month) EvaluationMostBMTpatientswillhaveaseriesoftestsdoneapproximately3monthsaftertheirtransplant.Thegoal
ofthisevaluationistoreassesstheoutcomesofthetransplant.Theworkuphastwopurposes:
1.Todeterminethestatusoftheunderlyingdisease(theoriginaldiagnosis)
2.Toassessanypossiblesideeffectsofthetreatment
The testsarenecessary toruleoutanypossiblecomplications.These testscandetermine if there isa
problemeventhoughtheremaybenosymptoms.Youwillbefamiliarwithmanyofthetests.
There isoften aone-yearpost-BMTevaluation for the same reasons listed above.Again,manyof the
testswillbefamiliartoyou.YourBMTdoctororthenurseswillgiveyoumoreinformationaboutthese
evaluationsasthedayapproaches.
PhasesofBMT•Discharge26 2727
Notes
L/BMTPatientEducationManual•TransplantModule
Notes
Notes
L/BMTPatientEducationManual•TransplantModule
Disclaimer:
Pleasenotethattheinformationcontainedinthismanualisnotintendedtoreplacetheadviceofyourhealthcareteam.
Usethisasareferenceandeducationguide.Consultyourhealthcareteamifyouhaveanyquestionsorconcerns.
Leukemia / Bone Marrow Transplant (BMT)Program of British Columbia
Mailing Address:
Leukemia/BMTProgramAdministration
10thFloor,2775LaurelStreet
Vancouver,BC
V5Z1M9
Telephone:
604-875-4863
Web Site:
www.leukemiabmtprogram.com
©2009Leukemia/BMTProgramofBC
FirstEdition:March2009